PRGO:NYSE
Perrigo Company PLC
$14.92
arrow_upward
+4.56%(+0.65) 1D
$14.95
arrow_upward
+0.20% (+0.030)bedtimeAfter hours
Closed: Sep 4, 4:00:05 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRGO...
Open
$14.07
High
$15.00
Low
$14.07
Mkt. cap
2.07B
Avg. vol.
2.85M
Volume
2.20M
Dividend
7.77%
Quarterly dividend
$0.29
Ex-dividend date
Aug 28, 2026
52-wk high
$23.68
52-wk low
$9.22
EPS
-$12.59
Beta
0.58
Shares outstanding
138.77M
No. of employees
8K
Open
$14.07
High
$15.00
Low
$14.07
Mkt. cap
2.07B
Avg. vol.
2.85M
Volume
2.20M
Dividend
7.77%
Quarterly dividend
$0.29
Ex-dividend date
Aug 28, 2026
52-wk high
$23.68
52-wk low
$9.22
EPS
-$12.59
Beta
0.58
Shares outstanding
138.77M
No. of employees
8K
Profile
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
About Perrigo Company PLC
CEOMurray S. Kessler
Employees8.1K
Founded1887
Headquarters-
SectorPharmaceutical industry
Websiteperrigo.com